S. R. Hubbard, The insulin receptor: both a prototypical and atypical receptor tyrosine kinase, Cold Spring Harb. Perspect. Biol, vol.5, p.8946, 2013.

J. A. Hedo, C. R. Kahn, M. Hayashi, K. M. Yamada, and M. Kasuga, Biosynthesis and glycosylation of the insulin receptor: evidence for a single polypeptide precursor of the two major subunits, J. Biol. Chem, vol.258, pp.10020-10026, 1983.

Y. Ebina, L. Ellis, K. Jarnagin, M. Edery, L. Graf et al., The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling, Cell, vol.40, pp.747-758, 1985.

A. Ullrich, J. R. Bell, E. Y. Chen, R. Herrera, L. M. Petruzzelli et al., Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes, Nature, vol.313, pp.756-761, 1985.

M. Kobayashi, T. Sasaoka, Y. Takata, A. Hisatomi, and Y. Shigeta, Insulin resistance by uncleaved insulin proreceptor: emergence of binding site by trypsin, Diabetes, vol.37, pp.653-656, 1988.

Y. Yoshimasa, S. Seino, J. Whittaker, T. Kakehi, A. Kosaki et al., Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing, Science, vol.240, pp.784-787, 1988.

D. Dardevet, K. Komori, C. Grunfeld, S. A. Rosenzweig, and M. G. Buse, Increased hepatic insulin proreceptor-to-receptor ratio in diabetes: a possible processing defect, Am. J. Physiol, vol.261, pp.562-571, 1991.

N. G. Seidah and A. Prat, The biology and therapeutic targeting of the proprotein convertases, Nat. Rev. Drug Discov, vol.11, pp.367-383, 2012.

J. Bass, C. Turck, M. Rouard, and D. F. Steiner, Furin-mediated processing in the early secretory pathway: sequential cleavage and degradation of misfolded insulin receptors, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.11905-11909, 2000.

B. J. Robertson, J. M. Moehring, and T. J. Moehring, Defective processing of the insulin receptor in an endoprotease-deficient Chinese hamster cell strain is corrected by expression of mouse furin, J. Biol. Chem, vol.268, pp.24274-24277, 1993.

Y. Yoshimasa, J. I. Paul, J. Whittaker, and D. F. Steiner, Effects of amino acid replacements within the tetrabasic cleavage site on the processing of the human insulin receptor precursor expressed in Chinese hamster ovary cells, J. Biol. Chem, vol.265, pp.17230-17237, 1990.

D. Bernot, J. Stalin, P. Stocker, B. Bonardo, I. Scroyen et al., Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase, J. Cell Sci, vol.124, pp.1224-1230, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01460284

A. J. Roebroek, N. A. Taylor, E. Louagie, I. Pauli, L. Smeijers et al., Limited redundancy of the proprotein convertase furin in mouse liver, J. Biol. Chem, vol.279, pp.53442-53450, 2004.

J. F. Sucic, J. M. Moehring, N. M. Inocencio, J. W. Luchini, and T. J. Moehring, Endoprotease PACE4 is Ca 2? -dependent and temperature-sensitive and can partly rescue the phenotype of a furin-deficient cell strain, Biochem. J, vol.339, pp.639-647, 1999.

S. Seino and G. I. Bell, Alternative splicing of human insulin receptor messenger RNA, Biochem. Biophys. Res. Commun, vol.159, pp.312-316, 1989.

A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri, Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease, Endocr. Rev, vol.30, pp.586-623, 2009.

S. Benyoucef, K. H. Surinya, D. Hadaschik, and K. Siddle, Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation, Biochem. J, vol.403, pp.603-613, 2007.

F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo et al., Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells, Mol. Cell Biol, vol.19, pp.3278-3288, 1999.

Y. Yamaguchi, J. S. Flier, H. Benecke, B. J. Ransil, and D. E. Moller, Ligand-binding properties of the two isoforms of the human insulin receptor, Endocrinology, vol.132, pp.1132-1138, 1993.

B. Vogt, J. M. Carrascosa, B. Ermel, A. Ullrich, and H. U. Häring, The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics, Biochem. Biophys. Res. Commun, vol.177, pp.1013-1018, 1991.

Y. Yamaguchi, J. S. Flier, A. Yokota, H. Benecke, J. M. Backer et al., Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells, Endocrinology, vol.129, pp.2058-2066, 1991.

B. Leibiger, I. B. Leibiger, T. Moede, S. Kemper, R. N. Kulkarni et al., Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells, Mol. Cell, vol.7, pp.559-570, 2001.

S. Uhles, T. Moede, B. Leibiger, P. O. Berggren, and I. B. Leibiger, Isoform-specific insulin receptor signaling involves different plasma membrane domains, J. Cell Biol, vol.163, pp.1327-1337, 2003.

S. Uhles, T. Moede, B. Leibiger, P. O. Berggren, and I. B. Leibiger, Selective gene activation by spatial segregation of insulin receptor B signaling, FASEB J, vol.21, pp.1609-1621, 2007.

D. A. Bravo, J. B. Gleason, R. I. Sanchez, R. A. Roth, and R. S. Fuller, Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus, J. Biol. Chem, vol.269, pp.25830-25837, 1994.

S. Tian, A 20 residue motif delineates the furin cleavage site and its physical properties may influence viral fusion, Biochem. Insights, vol.2, pp.9-20, 2009.

C. Levesque, M. Fugère, A. Kwiatkowska, F. Couture, R. Desjardins et al., The multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells, J. Med. Chem, vol.55, pp.10501-10511, 2012.

C. Auzan, A. Debant, B. Rossi, and E. Clauser, Cleavage site mutants of the subtype B insulin receptor are uncleaved and fully functional, 1997.

, Mol. Cell Endocrinol, vol.128, pp.129-137

F. Jean, K. Stella, L. Thomas, G. Liu, Y. Xiang et al., ?1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.7293-7298, 1998.

E. K. Dufour, A. Désilets, J. M. Longpré, and R. Leduc, Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation step, Protein Sci, vol.14, pp.303-315, 2005.

F. Peiretti, M. Canault, P. Deprez-beauclair, V. Berthet, B. Bonardo et al., Intracellular maturation and transport of tumor necrosis factor ? converting enzyme, Exp. Cell Res, vol.285, pp.278-285, 2003.

J. W. Creemers, L. E. Pritchard, A. Gyte, P. Le-rouzic, S. Meulemans et al., Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP), vol.147, pp.1621-1631, 2006.

R. M. Leonhardt, D. Fiegl, E. Rufer, A. Karger, B. Bettin et al., Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7, J. Immunol, vol.184, pp.2985-2998, 2010.

D. Bernot, E. Barruet, M. Poggi, B. Bonardo, M. C. Alessi et al., Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation, J. Biol. Chem, vol.285, pp.6508-6514, 2010.

J. M. Coppola, M. S. Bhojani, B. D. Ross, and A. Rehemtulla, A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness, Neoplasia, vol.10, pp.363-370, 2008.

R. Govers, D. E. James, and A. C. Coster, High-throughput analysis of the dynamics of recycling cell surface proteins, Methods Mol. Biol, vol.440, pp.129-146, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01478370

N. Vidal, J. P. Cavaillé, M. Poggi, F. Peiretti, and P. Stocker, A nonradioisotope chemiluminescent assay for evaluation of 2-deoxyglucose uptake in 3T3-L1 adipocytes. Effect of various carbonyls species on insulin action, Biochimie, vol.94, pp.2569-2576, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01460418

S. Tian, W. Huajun, and J. Wu, Computational prediction of furin cleavage sites by a hybrid method and understanding mechanism underlying diseases, Sci. Rep, vol.2, p.261, 2012.

N. G. Seidah, G. Mayer, A. Zaid, E. Rousselet, N. Nassoury et al., The activation and physiological functions of the proprotein convertases, Int. J. Biochem. Cell Biol, vol.40, pp.1111-1125, 2008.

A. Tsuji, K. Sakurai, E. Kiyokage, T. Yamazaki, S. Koide et al., Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix, Biochim. Biophys. Acta, vol.1645, pp.95-104, 2003.

G. L. Becker, K. Hardes, and T. Steinmetzer, New substrate analogue furin inhibitors derived from 4-amidinobenzylamide, Bioorg Med. Chem. Lett, vol.21, pp.4695-4697, 2011.

N. Nour, G. Mayer, J. S. Mort, A. Salvas, M. Mbikay et al., The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases, Mol. Biol. Cell, vol.16, pp.5215-5226, 2005.

R. Essalmani, D. Susan-resiga, A. Chamberland, M. C. Asselin, M. Canuel et al., Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes, J. Biol. Chem, vol.288, pp.26410-26418, 2013.

N. G. Seidah, M. Chrétien, and R. Day, The family of subtilisin/ kexin like pro-protein and pro-hormone convertases: divergent or shared functions, Biochimie, vol.76, pp.197-209, 1994.

G. Mayer, J. Hamelin, M. C. Asselin, A. Pasquato, E. Marcinkiewicz et al., The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates, J. Biol. Chem, vol.283, pp.2373-2384, 2008.

M. Pashmforoush, Y. Yoshimasa, and D. F. Steiner, Exon 11 enhances insulin binding affinity and tyrosine kinase activity of the human insulin proreceptor, J. Biol. Chem, vol.269, pp.32639-32648, 1994.

A. Salzman, C. F. Wan, and C. S. Rubin, Biogenesis, transit, and functional properties of the insulin proreceptor and modified insulin receptors in 3T3-L1 adipocytes. Use of monensin to probe proreceptor cleavage and generate altered receptor subunits, Biochemistry, vol.23, pp.6555-6565, 1984.

T. Sasaoka, Y. Shigeta, Y. Takata, M. Sugibayashi, A. Hisatomi et al., Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance, Diabetologia, vol.32, pp.371-377, 1989.

A. Basak, A. Chen, N. Scamuffa, D. Mohottalage, S. Basak et al., Blockade of furin activity and furin-induced tumor cells malignant phenotypes by the chemically synthesized human furin prodomain, Curr. Med. Chem, vol.17, pp.2214-2221, 2010.

D. E. Bassi, R. Lopez-de-cicco, H. Mahloogi, S. Zucker, G. Thomas et al., Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells, Proc. Natl. Acad. Sci. U.S.A, vol.98, pp.10326-10331, 2001.

C. Lalou, A. Basak, P. Mishra, B. C. Mohanta, R. Banik et al., Inhibition of tumor cells proliferation and migration by the flavonoid furin inhibitor isolated from Oroxylum indicum, Curr. Med. Chem, vol.20, pp.583-591, 2013.